The treatment primarily aims to normalize or reduce prolactin hormone levels, decrease tumor size, improve focal neurologic symptoms caused by compression, achieve eugonadism by normalizing testosterone levels, and restore the hormonal axis affected by the tumor. Here, PRL is linked to neoplasm.